Smith & Nephew plc

Smith & Nephew plc

SNNUF

$13.74

Updated: 23/09/2026, 18:11:03

Market Cap
$11.54B
Sector
Healthcare
Industry
Medical - Devices
Country
GB
Stock valuation chart
One-year closing share-price history for SNNUF
Company Profile

Smith & Nephew plc is a global medical technology enterprise dedicated to the development, manufacturing, and worldwide commercialization of an extensive array of medical devices. Its product portfolio spans several key areas. In orthopedics, the company provides knee implants for replacement procedures, hip implants for joint reconstruction, and trauma and extremities products, including both internal and external fixation devices, crucial for stabilizing severe fractures and correcting deformities. For sports medicine, Smith & Nephew offers joint repair solutions tailored for surgeons. This includes specialized instruments, advanced technologies, and implants essential for minimally invasive joint surgeries, targeting soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, the firm supplies arthroscopic enabling technologies that enhance surgical visualization and intervention within joints. This suite encompasses fluid management equipment for surgical access, high-definition cameras, digital imaging capture systems, scopes, light sources, and monitors. It also features radiofrequency, electromechanical, and mechanical tissue resection devices, alongside hand instruments for precise tissue removal. The company also provides dedicated ear, nose, and throat (ENT) solutions. Its Advanced Wound Management division delivers comprehensive solutions for the treatment and prevention of acute and chronic wounds, covering conditions like leg, diabetic, and pressure ulcers, burns, and post-operative wounds. This segment includes advanced wound bioactives, comprising biologics and other bioactive technologies for debridement, dermal repair, and regeneration. Regenerative medicine products, such as skin, bone graft, and articular cartilage substitutes, are also offered. Furthermore, Smith & Nephew provides advanced wound devices, including traditional and single-use negative pressure wound therapy systems, and hydrosurgery technology. Primarily serving healthcare providers globally, Smith & Nephew plc was founded in 1856 and is headquartered in Watford, United Kingdom.

USD
OTC
CEO: Deepak S. Nath
Employees: 18,362
https://www.smith-nephew.com
Asset Summaries
Latest generated summaries for SNNUF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SNNUF.
Share price
$13.74
Market cap
$11.54B
Exchange
OTC
Currency
USD
CEO
Deepak S. Nath
Employees
18,362
IPO date
21/04/2009
Beta
0.553
Last dividend
$0.00
Day range
$13.74 – $15.75
52-week range
$13.10 – $18.50
1-day performance
-11.24%
1-year performance
4.89%
Current drawdown (1Y)
-25.73%
CIK
0000845982
CUSIP
83175M205
ISIN
GB0009223206
Created
07/12/2025, 14:18:41
Last update
23/09/2026, 18:11:03

Track Smith & Nephew plc with an AI analyst

See which prediction-market events move SNNUF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SNNUF from your Railway `news_articles` table.

No news found for this symbol.